SiteOne Raises $100m For Peripheral Nervous System-Targeting Drugs In Pain And More

Lead Asset Competes With Vertex’s NaV1.8 Inhibitor

SiteOne is researching and developing drugs for pain and other conditions (Shutterstock)

More from Financing

More from Scrip